Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Flexible Dose Regimen Comparison
NCT03691038Terminated
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of pregabalin in neuropathic pain (2 arms), sponsored by Kangbuk Samsung Hospital. Primary endpoint: Discontinuation of medication at 7 weeks. Started Oct 2018; status: terminated.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03691038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691038.